sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
ttaagatgacacatgcagcttag | 1321 | EP4221838A1 | Snca irna compositions and methods of use thereof for treating or preventing snca-associated neurodegenerative diseases | 20,230,809 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ttaagatgacacatgcagcttag | 1321 | EP4221838A1 | SNCA-IRNA-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON ZUR BEHANDLUNG ODER PRÄVENTION VON SNCA-ASSOZIIERTEN NEURODEGENERATIVEN ERKRANKUNGEN | 20,230,809 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ttaagatgacacatgcagcttag | 1321 | EP4221838A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,230,809 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ttaagatgacacatgcagcttag | 1047 | EP4221838A1 | Snca irna compositions and methods of use thereof for treating or preventing snca-associated neurodegenerative diseases | 20,230,809 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ttaagatgacacatgcagcttag | 1047 | EP4221838A1 | SNCA-IRNA-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON ZUR BEHANDLUNG ODER PRÄVENTION VON SNCA-ASSOZIIERTEN NEURODEGENERATIVEN ERKRANKUNGEN | 20,230,809 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ttaagatgacacatgcagcttag | 1047 | EP4221838A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,230,809 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agaguauguguaaaaaucugu | 1146 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agaguauguguaaaaaucugu | 1508 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agaguauguguaaaaaucugu | 1146 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agaguauguguaaaaaucugu | 798 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agaguauguguaaaaaucugu | 798 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agaguauguguaaaaaucugu | 428 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agaguauguguaaaaaucugu | 428 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agaguauguguaaaaaucugu | 1508 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
guggagaaaacaaccuaaa | 72 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
guggagaaaacaaccuaaa | 72 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
guccauggacauuaauuca | 22 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
guccauggacauuaauuca | 22 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 879 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 1331 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 1693 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 509 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 1693 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 879 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 509 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 1331 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acuuguaguuuauauguag | 106 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acuuguaguuuauauguag | 106 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 441 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 811 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 811 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 1429 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 1429 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 441 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 1067 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 1067 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agacugaucaaauauguug | 126 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agacugaucaaauauguug | 126 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaagguuauacucuauaaa | 304 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaagguuauacucuauaaa | 1534 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaagguuauacucuauaaa | 1534 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaagguuauacucuauaaa | 1172 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaagguuauacucuauaaa | 674 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaagguuauacucuauaaa | 1172 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaagguuauacucuauaaa | 304 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaagguuauacucuauaaa | 674 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugucacuugaacucaacucaa | 1078 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugucacuugaacucaacucaa | 266 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugucacuugaacucaacucaa | 636 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugucacuugaacucaacucaa | 266 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugucacuugaacucaacucaa | 1440 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugucacuugaacucaacucaa | 636 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugucacuugaacucaacucaa | 1440 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugucacuugaacucaacucaa | 1078 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caacagcauagucaaauaa | 67 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caacagcauagucaaauaa | 67 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuaacuaacuuaauucaaa | 26 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuaacuaacuuaauucaaa | 25 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuaacuaacuuaauucaaa | 25 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuaacuaacuuaauucaaa | 26 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 563 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 563 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 1304 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 1666 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 1666 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 933 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 933 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 1304 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugaggcaaauuuaaaaggcaa | 1162 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugaggcaaauuuaaaaggcaa | 437 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugaggcaaauuuaaaaggcaa | 807 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugaggcaaauuuaaaaggcaa | 1524 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugaggcaaauuuaaaaggcaa | 1162 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugaggcaaauuuaaaaggcaa | 1524 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugaggcaaauuuaaaaggcaa | 437 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ugaggcaaauuuaaaaggcaa | 807 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caaaaacucaacauauuugau | 1370 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caaaaacucaacauauuugau | 321 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caaaaacucaacauauuugau | 1008 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caaaaacucaacauauuugau | 691 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caaaaacucaacauauuugau | 321 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caaaaacucaacauauuugau | 1370 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caaaaacucaacauauuugau | 1008 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caaaaacucaacauauuugau | 691 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auucuccaucaagccuccc | 107 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auucuccaucaagccuccc | 107 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauaguugguuucgugauuuccc | 1298 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauaguugguuucgugauuuccc | 1660 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauaguugguuucgugauuuccc | 892 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauaguugguuucgugauuuccc | 522 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauaguugguuucgugauuuccc | 522 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauaguugguuucgugauuuccc | 1298 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauaguugguuucgugauuuccc | 892 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauaguugguuucgugauuuccc | 1660 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaacucaacucaaaacuugaa | 736 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaacucaacucaaaacuugaa | 366 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaacucaacucaaaacuugaa | 736 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaacucaacucaaaacuugaa | 1055 | US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,210,928 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaacucaacucaaaacuugaa | 1055 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaacucaacucaaaacuugaa | 1417 | US20210171955A1 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,210,610 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.